Mengembalikan Makna Bernapas
DOI:
https://doi.org/10.56951/rvt1y058Editorial
Tata laksana penyakit saluran pernapasan bawah, seperti bronkitis, penyakit paru obstruktif kronis (PPOK), dan bronkiektasis menjadi tantangan yang signifikan, terutama di negara dengan tingkat polusi udara yang tinggi, kebiasaan merokok, dan prevalensi infeksi yang tinggi. Batuk sebagai salah satu gejala utama, merupakan mekanisme pertahanan tubuh untuk menjaga kebersihan dan kelancaran saluran pernapasan, oleh karena itu, batuk perlu ditangani dengan tepat agar mukus dapat diekspektorasi secara efisien, salah satunya dengan menggunakan agen mukolitik seperti bromhexine. Pendekatan modern dalam penanganan infeksi saluran pernapasan menekankan intervensi farmakologis dan dukungan fisiologis. Terapi farmakologis berfokus pada pemulihan fungsi napas dan rasionalitas terapi, dengan cara mengendalikan inflamasi, mengatur drainase mukus, serta penggunaan antibiotik yang rasional. Intervensi fisiologis seperti rehabilitasi paru dan program berhenti merokok memberikan dampak jangka panjang yang signifikan terhadap kualitas hidup pasien.
Unduhan
Referensi
1. Canning BJ, Chang AB, Bolser DC, Smith JA, Mazzone SB, McGarvey L. Anatomy and neurophysiology of cough. Chest. 2014;146(6):1633–48. https://doi.org/10.1378/chest.14-1481.
2. Choi H, McShane PJ, Aliberti S, Chalmers JD. Bronchiectasis management in adults: state of the art and future directions. Eur Respir J. 2024;63(6). https://doi.org/10.1183/13993003.00518-2024.
3. Doumat G, Aksamit TR, Kanj AN. Bronchiectasis: a clinical review of inflammation. Respir Med. 2025;244:108179. https://doi.org/10.1016/j.rmed.2025.108179.
4. Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, et al. British Thoracic Society guideline for bronchiectasis in adults. BMJ Open Respir Res. 2018;5(1):e000348. https://doi.org/10.1136/bmjresp-2018-000348.
5. Koarai A, Yamada M, Ichikawa T, Fujino N, Sugiura H. Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysis. Respir Investig. 2024;62(3):503–11. https://doi.org/10.1016/j.resinv.2024.03.009.
6. Lee YQ, Selvakumar A, See KC. Treatable traits in chronic respiratory disease: a comprehensive review. Cells. 2021;10(11):3263. https://doi.org/10.3390/cells10113263.
7. Nakagawa N, Ito M, Asakura T, Horita N, Obase Y, Mukae H. Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis. Respir Investig. 2024;62(6):1079–87. https://doi.org/10.1016/j.resinv.2024.09.004.
8. Ohnishi H, Tanimoto T, Inaba R, Eitoku M. Efficacy and safety of mucolytics in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Investig. 2024;62(6):1168–75. https://doi.org/10.1016/j.resinv.2024.10.004.
9. Olivieri D, Ciaccia A, Marangio E, Marsico S, Todisco T, Del Vita M. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo. Respiration. 1991;58(3–4):117–21. https://doi.org/10.1159/000195910.
10. Raherison C, Aguilaniu B, Zysman M, Burgel P-R, Hess D, Ouaalaya EH, et al. Influenza and pneumococcal vaccination in patients with COPD from 3 French cohorts: insufficient coverage and associated factors. Respir Med Res. 2024;86:101112. https://doi.org/10.1016/j.resmer.2024.101112.
11. Strickland SL, Rubin BK, Haas CF, Volsko TA, Drescher GS, O’Malley CA. AARC Clinical practice guideline: effectiveness of pharmacologic airway clearance therapies in hospitalized patients. Respir Care. 2015;60(7):1071–7. https://doi.org/10.4187/respcare.04165.
12. Sykes DL, Morice AH. The cough reflex: the janus of respiratory medicine. Front Physiol. 2021;12. https://doi.org/10.3389/fphys.2021.684080.
13. Tjandrawinata R. Polusi udara dan dampaknya pada kesehatan. Warta Ekonomi. 2024 Mei.
14. Webb EM, Holland AE, Chang AB, Burr L, Holmes-Liew C-L, King PT, et al. Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registry. Respir Med. 2024;233:107777. https://doi.org/10.1016/j.rmed.2024.107777.
15. Zanasi A, Mazzolini M, Kantar A. A reappraisal of the mucoactive activity and clinical efficacy of bromhexine. Multidiscip Respir Med. 2017;12:7. https://doi.org/10.1186/s40248-017-0088-1.
Unduhan
Terbitan
Bagian
Diterbitkan
Unduhan
Lisensi
Hak Cipta (c) 2025 Raymond R. Tjandrawinata
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
Cara Mengutip
